Deal net: 6 – 10 February 2017

The Global Government Venturing deal net rounds up all the latest smaller deals and tracks emerging companies accessing government funds.

Atriva Therapeutics, a Germany-based developer of antiviral therapies, has received an undisclosed amount in seed funding co-led by public-private partnership High-Tech Gründerfonds and Stichting Participatie Artriva. A range of private investors also participated in the round, which will support the advancement of the startup’s therapy for influenza into the clinical development stage.

See more from this Government Report: Germany

Back

Copyright Mawsonia Limited 2010. Please don't cut articles from www.globalgovernmentventuring.com or the PDF and redistribute by email or post to the web without written permission.

Most read

  1. News round up 2 January 2018

    January 02, 2018

  2. 2017: year in review

    January 10, 2018

  3. News round up 22 January 2018

    January 22, 2018

  4. Temasek and EDBI take a slice of Pear

    January 03, 2018

  5. WM Motor revs up with new funding

    December 28, 2017